Texas Biomedical Research Institute studying Omicron variant, urges vaccines

Texas Biomedical Research Institute President, CEO discusses COVID-19 in USПодробнее

Pfizer starting trials to create vaccine specific to omicron variantПодробнее

Texas Biomedical Research Institute weighs in on booster Pfizer vaccinesПодробнее

Interview with Dr. Larry Schlesinger, Texas Biomed CEO, on COVID-19 vaccineПодробнее

COVID-19 Research UpdateПодробнее

Predicting PandemicsПодробнее

Study by Texas Biomed shows hope for Zika vaccineПодробнее

KSAT Explains debrief: Work at Texas Biomedical Research Institute has provided hope amid pandemicПодробнее

Golden Circle COVID19 BriefingПодробнее

Texas BioMed CEO reflects on its crucial role in vaccine developmentПодробнее

Texas Biomed teams up with scientists across the country to fight coronavirusПодробнее

Texas Biomed Unraveling The Mysteries Of Infectious DiseasesПодробнее

Texas medical experts, travelers react to new COVID-19 ‘variant of concern,’ OmicronПодробнее

KSAT Q&A: Dr. Larry Schlesinger, CEO of Texas Biomedical Research Institute, explains COVID-19 v...Подробнее

Texas Biomedical Research Institute gets national recognitionПодробнее

Texas Biomed requiring employees to be vaccinated against COVID-19Подробнее

University of Texas researchers study COVID-19 omicron variant | KVUEПодробнее

Local researchers launch new study to find coronavirus vaccineПодробнее

Texas Biomed to expand facilities, bring new jobs to San AntonioПодробнее